ORIGINAL RESEARCH article
Front. Oncol.
Sec. Head and Neck Cancer
Volume 15 - 2025 | doi: 10.3389/fonc.2025.1589919
This article is part of the Research TopicPathophysiology and Therapeutic Strategies for Oral and Head and Neck CancersView all 14 articles
Construction of an Oligometastatic Prediction Model for Nasopharyngeal Carcinoma Patients Based on Pathomics Features and Machine Learning
Provisionally accepted- 1The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China
- 2School of Nursing, Southwest Medical University, Luzhou, China
- 3Southwest Medical University, Luzhou, Sichuan, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Objective: This study aimed to develop a risk prediction model for post-treatment oligometastasis in nasopharyngeal carcinoma (NPC) by integrating pathomics features and an improved Support vector machine (SVM) algorithm, offering precise early decision support.: This study retrospectively included 462 NPC patients, without or with oligometastasis defined by ESTRO/EORTC criteria. Whole-slide images were scanned, and three representative H&E-stained regions were selected for pathomics feature extraction via CellProfiler software. Features screened by intraclass correlation coefficient, Mann-Whitney U test, Spearman correlation, minimum redundancy maximum relevance, and Least absolute shrinkage and selection operator regression. Based on these screened features, three models were built: Dynamic Multi-Swarm Particle Swarm Optimization SVM (DMS-PSO-SVM), Particle Swarm Optimization SVM (PSO-SVM), and a standard SVM. Model training and hyperparameter tuning were conducted on the training set (n=369), followed by evaluation on an independent validation set (n=93). Results: 6 pathomics features were screened as important features. DMS-PSO-SVM yielded superior performance, with training-set AUC=0.880 and validation-set AUC=0.866, consistently outperforming both PSO-SVM (AUC=0.721) and standard SVM (AUC=0.718). Calibration curves showed good agreement for DMS-PSO-SVM (P>0.05) but indicated miscalibration in the standard SVM (P<0.05). Decision curve analysis further demonstrated that DMS-PSO-SVM offered higher net benefit across a wide range of risk thresholds. Conclusion: Incorporating pathomics and DMS-PSO optimization significantly improved NPC oligometastasis prediction. This model showed high discriminative ability, calibration, and clinical utility, suggesting that pathomics and machine learning-based strategies could aid early recognition of high-risk patients and inform individualized treatment approaches. A demo of the DMS-PSO-SVM modeling algorithm code used in this study can be found on Github (https://github.com/Edward-E-S-Wang/DMS-PSO-SVM).
Keywords: machine learning, Prediction model, metastases, nasopharyngeal carcinoma, Pathomics, Support vector machine
Received: 08 Mar 2025; Accepted: 20 May 2025.
Copyright: © 2025 Li, Zhang, Wang, Hu, Wen, Yang, Zhou and Cheng. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Yiren Wang, School of Nursing, Southwest Medical University, Luzhou, China
Ping Zhou, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, Sichuan, China
Wen-Hui Cheng, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, Sichuan, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.